Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Christy Ralph Bernard Escudier Robert Motzer Alain Ravaud |
| Publication date | March 7, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |